We observed that H2AFZ and MCM2 were expressed at relatively high levels in CMM12 melanoma cells compared to the other cell lines, suggesting a possible utility of E2F target gene expression in tumor cells as markers to predict response to treatment with a CDK4/6 inhibitor. Here, H2AZ2 is linked to neoplasm.